Schmidt, AT
Achim Schmidt, Graz AT
Patent application number | Description | Published |
---|---|---|
20120193949 | BACKREST OF SEAT OR A BENCH WITH AN INTEGRATED WIND DEFECTOR - A motor vehicle seat including a seat portion having a wind deflector provided in a storage compartment thereof, the wind deflector being mounted for movement between a rest position in the storage compartment and an active position out of the storage compartment. The seat portion also has a rotational joint configured to permit rotation of the seat portion between a first orientation in which the seat portion permits a user to assume a seated position, and a second orientation in which the seat portion permits the wind deflector to assume the active position. | 08-02-2012 |
20120193952 | SEAT OR BENCH FOR A MOTOR VEHICLE - A motor vehicle including at least one seat and/or at least one bench having a seat surface and a backrest. The backrest can be moved into a position above the seat surface in which the backrest and the seat surface lie opposite one another. In addition, the front edge of the seat surface and an edge of the backrest that lies closest to it can be connected with an additional element, for example, a roller blind or a plate. | 08-02-2012 |
Eric Schmidt, Grosskrut AT
Patent application number | Description | Published |
---|---|---|
20120210085 | METHOD FOR EXECUTING SECURITY-RELEVANT AND NON-SECURITY-RELEVANT SOFTWARE COMPONENTS ON A HARDWARE PLATFORM - A method for executing safety-relevant and non-safety-relevant software components on a hardware platform comprising a computer, memory and a monitoring component that operates independently of the computer. The safety-relevant software component erects a memory protection against access of a non-safety-relevant function to at least one area of the memory of the safety-relevant function before execution of the non-safety-relevant software component, so that the non-safety-relevant software component does not have access to the areas of the memory being used for safety-relevant components. After the return from the non-safety-relevant component, the memory protection is deactivated and the monitoring function monitors the safety-relevant function for its proper operation. | 08-16-2012 |
Georg Schmidt, Salzburg AT
Patent application number | Description | Published |
---|---|---|
20100104606 | ALLERGEN FRAGMENTS - The present invention relates to a peptide derived from the ragweed pollen allergen Amb a (1) and comprising (6 to 50) amino acid residues and pharmaceutical preparations comprising said peptide and uses thereof. | 04-29-2010 |
Heinrich Schmidt, Vocklabruck AT
Patent application number | Description | Published |
---|---|---|
20110212833 | Process For The Manufacture Of Solid Regenerated Viscose Fibers - The present invention concerns a process for the manufacture of solid regenerated viscose fibres, comprising the steps of: —spinning a viscose spinning dope through a spinneret comprising spinning holes into a regenerating bath thereby forming filaments, —said viscose spinning dope having an alkali ratio immediately before spinning of from 0.7 to 1.0, preferably from 0.8 to 0.9, —at least part of said spinning holes having a circular orifice, —said regenerating bath containing—from 70 to 120 g/l, preferably 90 to 110 g/l sulfuric acid, —from 240 to 380 g/l, preferably 330 to 370 g/l sodium sulphate, —form 20 to 50 g/l, preferably 25 to 35 g/l zinc sulphate and said regenerating bath having a temperature of from 45 to 55° C., preferably 48 to 50° C., —stretching said filaments after leaving said regenerating bath in a secondary bath and/or in air at a stretching ratio of from 70% to 90%, preferably 80% to 90% of the maximum stretching ratio as hereinbefore defined and—treating said filaments with a fatty acid ester. | 09-01-2011 |
Johann Schmidt, Graz AT
Patent application number | Description | Published |
---|---|---|
20100141098 | Piezoelectric Multilayer Component - A piezoelectric multilayer component has a base body including a stack of dielectric layers, electrode layers and at least one predetermined breaking layer. The predetermined breaking layer is arranged at least for the most part in an inactive zone of the multilayer component and cracks under specific tensile loads. | 06-10-2010 |
20130342083 | ACTUATOR, ACTUATOR SYSTEM, AND CONTROL OF AN ACTUATOR - The invention relates to an actuator ( | 12-26-2013 |
20140022695 | Electrical Multilayer Component - An electrical multilayer component includes a stack composed of functional layers and also a first and a second external contact. The external contacts are arranged on side surfaces of the stack. Internal electrodes of a first type are directly electrically conductively connected to the first external contact and internal electrodes of a second type directly electrically conductively connected to the second external contact. An internal electrode of the first type and an internal electrode of the second type partly overlap. An internal electrode of the first type and an internal electrode of the second type are arranged in a manner spaced apart from one another in an identical plane. | 01-23-2014 |
Juergen Schmidt, Vienna AT
Patent application number | Description | Published |
---|---|---|
20150348125 | CONTENT-DRIVEN ADVERTISING NETWORK PLATFORM - A method of automatically selecting a first advertisement for a product according to real time network actions is described. A first content thematically associated with a first advertisement is displayed to a visitor of a third party website. The first content may be free of any explicit reference to a brand or manufacturer of the product. A teaser for the product may be source indistinguishable to the user from other content teasers on the platform. Upon selection of a content teaser, the content is delivered together with the first advertisement. More than one content teaser may be provided for each piece of content and a set of pieces of content may be cycled for the first advertisement. The content teasers and the content pieces displayed may then be optimized based on click through rates. | 12-03-2015 |
Marcus Schmidt, Axams AT
Patent application number | Description | Published |
---|---|---|
20140094874 | Implant Sensor and Control - An implant includes a humidity sensor for generating a signal indicative of humidity within the implant. A controller within the implant receives the signal indicative of humidity, and controls the implant based on the signal indicative of humidity. | 04-03-2014 |
Marcus Schmidt, Innsbruck AT
Patent application number | Description | Published |
---|---|---|
20080200779 | Implant Sensor and Control - An implant includes a humidity sensor for generating a signal indicative of humidity within the implant. A controller within the implant receives the signal indicative of humidity, and controls the implant based on the signal indicative of humidity. | 08-21-2008 |
20100305677 | Middle Ear Fixation Structure - An implantable fixation structure includes a c-shape bone fixation clip adapted to fit over and attach to a bony bridge element in the middle ear of a patient. A c-shape electrode fixation clip is adapted to fit over and attach to an electrode array element in the middle ear of the patient. A connecting bar has a first end connected to the bone fixation clip and a second end connected to the electrode fixation clip. A coupling clip is connected to the connecting bar between the first end and the second end and adapted to fit over and attach to a cochlear implant element and hold the cochlear implant element in a desired position relative to the middle ear of the patient. | 12-02-2010 |
Oskar Schmidt, Wien AT
Patent application number | Description | Published |
---|---|---|
20090130052 | Biocide, in particular an agent with fungicidal activity - The invention relates to a polymeric condensation product which can be obtained by reacting guanidine or its salt with an alkylene diamine and an oxyalkylene diamine. Said condensation product has biocidal, in particular fungicidal, activity and is usable as a plant protection product. | 05-21-2009 |
20100303752 | USE OF POLYMERIC GUANIDINES FOR CONTROLLING MICROORGANISMS - The invention relates to the use of polymeric guanidinium hydroxides based on a diamine which contains oxyalkylene chains and/or alkylene groups between two amino groups, obtainable by polycondensation of a guanidine acid addition salt with the diamine, whereby a polycondensation product in the form of a salt is obtained, which subsequently is converted into the hydroxide form via basic anion exchange, for controlling microorganisms. | 12-02-2010 |
20110003689 | USE OF POLYMERIC GUANIDINE DERIVATIVES FOR THE CONTROL OF UNWANTED MICROORGANISMS IN CROP PROTECTION - The present invention relates to the use of polymeric guanidine derivatives for the curative and/or preventive treatment of unwanted microorganisms such as bacteria and phytopathogenic fungi in crop protection including the treatment of seed. The invention furthermore relates to novel active compound combinations comprising at least one polymeric guanidine derivative and at least one further fungicidally active compound, their use for the curative or preventive treatment of unwanted microorganisms in crop protection including the treatment of seed and not least the treated seed itself. | 01-06-2011 |
20130315982 | LIPOSOMAL DRUG COMPOSITION CONTAINING A POLYMERIC GUANIDINE DERIVATIVE - A liposomal drug composition comprising: a dimeric or polymeric guanidine derivative or a pharmaceutically acceptable salt thereof as drug substance, and a lipid modified by polyethylene glycole (PEG). The drug composition have cytostatic and antimicrobial activity. | 11-28-2013 |
Oskar Schmidt, Vienna AT
Patent application number | Description | Published |
---|---|---|
20110076766 | Cytostatic Drug Composition - A drug composition containing as a drug substance a polymeric guanidine derivative based on a diamine containing oxyalkylene chains between two amino groups, with the guanidine derivative representing a product of polycondensation between a guanidine acid addition salt and a diamine containing polyalkylene chains between two amino groups, as well as the pharmaceutically acceptable salts thereof. | 03-31-2011 |
20130040388 | CYTOSTATIC DRUG COMPOSITION - A drug composition containing as a drug substance a polymeric guanidine derivative based on a diamine containing oxyalkylene chains between two amino groups, with the guanidine derivative representing a product of polycondensation between a guanidine acid addition salt and a diamine containing polyalkylene chains between two amino groups, as well as the pharmaceutically acceptable salts thereof. | 02-14-2013 |
Reinhold Schmidt, Graz AT
Patent application number | Description | Published |
---|---|---|
20110217918 | DEVICE AND METHOD FOR JAMMER RESISTANCE IN BROADBAND RECEIVERS - A multiband heterodyne receiver, and method, having a source of a received signal, a local oscillator that outputs a local oscillator signal, and a mixer that combines the received signal and the local oscillator signal to generate a combined signal. The local oscillator signal can be adjusted in accordance with a detected jamming signal. A DC filter receives the combined signal and attenuates a DC component of the combined signal so as to output a DC filtered signal, and an analog-to-digital converter receives the DC filtered signal and converts the DC filtered signal to a digital signal. | 09-08-2011 |
Ulrike Schmidt, Leonding AT
Patent application number | Description | Published |
---|---|---|
20130036868 | PROCESS FOR PRODUCING PIG IRON OR LIQUID PRIMARY STEEL PRODUCTS - A process for producing pig iron or liquid primary steel products is provided. Charge materials containing iron ore and, if appropriate, additions are reduced in at least one reduction unit by means of a reducing gas, and at least parts thereof are smelted in a smelting unit, with coal being added and with formation of the reducing gas. Reducing gas from the smelting unit and/or top gas from the reduction unit are/is subjected to cleaning. The process water obtained during the wet cleaning is degassed and in the process volatile organic compounds are removed from the process water. | 02-14-2013 |
20130284019 | Method And Apparatus For Treating Process Water - A method and apparatus are disclosed for treating process water which is loaded with gaseous compounds and/or possibly with solids and comes from a wet-cleaning installation for cleaning process gas, e.g., from a melt-reduction subassembly or from a direct-reduction subassembly. Process water is introduced in a tank in a first process stage and degassed on the basis of reduced solubility of the dissolved compounds. The tank has, on its upper side, a gas-collecting chamber, in which the separated-off gases are collected and from which these are discharged. Likewise, the treated process water is discharged from the tank via a drainage means. | 10-31-2013 |
Walter Schmidt, Vienna AT
Patent application number | Description | Published |
---|---|---|
20090004210 | Method for Preventing and Treating Alzheimer's Disease - The invention relates to the use of a compound comprising the following amino acid sequence X | 01-01-2009 |
20110092436 | COMPOUNDS FOR TREATING SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE - The present invention relates to a compound comprising a peptide for treating, preventing and/or ameliorating motor symptoms of Parkinson's disease, said peptide having a binding capacity to an antibody which is specific for an epitope of the amyloid-beta-peptide (Aβ). | 04-21-2011 |
20110201987 | COMBINATION THERAPY FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE, AND KIT THEREFOR - The invention relates to a method for preventing or treating Alzheimer's disease (AE). According to said method, a means for inducing a sequestration of amyloid β (Aβ) into a plasma is administered to a person, and the person is treated by means of an apheresis device comprising a fixed carrier that can come into contact with the blood or plasma flow and comprises a receptor binding an amyloid-β-precurser-protein (APP), the APP being removed from the blood of the person by means of the apheresis device. The invention also relates to a set for carrying out said method. | 08-18-2011 |
20110275556 | TREATMENT OF ATHEROSCLEROSIS - The present invention relates to the use of compounds for producing a medicament for preventing and/or treating atherosclerosis, atherosclerosis risk diseases and atherosclerosis sequelae. | 11-10-2011 |
20120269836 | Vaccine - Vaccine comprising a peptide bound to a pharmaceutically acceptable carrier, said peptide having the amino acid sequence | 10-25-2012 |
20130183339 | METHODS AND COMPOSITIONS INVOLVING IMMUNOSTIMULATORY OLIGODEOXYNUCLEOTIDES - Described is an immunostimulatory oligodeoxynucleic acid molecule (ODN) having the structure according to formula (I), wherein any NMP is a 2′ deoxynucleoside monophosphate or monothiophosphate, selected from the group consisting of deoxyadenosine-, deoxyguanosine-, deoxyinosine-, deoxycytosine-, deoxyuridine-, deoxythymidine-, 2-methyl-deoxyinosine-, 5-methyl-deoxycytosine-, deoxypseudouridine-, deoxyribosepurine-, 2-amino-deoxyribosepurine-, -6-S-deoxyguanine-, 2-dimethyl-deoxyguanosine- or N-isopentenyl-deoxyadenosine-monophosphate or -monothiophosphate, NUC is a 2′ deoxynucleoside, selected from the group consisting of deoxyadenosine-, deoxyguanosine-, deoxyinosine-, deoxycytosine-, deoxyuridine-, deoxythymidine-, 2-methyl-deoxyinosine-, 5-methyl-deoxycytosine-, deoxypseudouridine-, deoxyribosepurine-, 2-amino-deoxyribosepurine-, 6-S-deoxyguanine-, 2-dimethyl-deoxyguanosine- or N-isopentenyl-deoxyadenosine, any X is O or S, a and b are integers from 0 to 100 with the proviso that a+b is between 4 and 150, B and E are common groups for 5′ or 3′ ends of nucleic acid molecules, as well as a pharmaceutical composition containing such ODNs. | 07-18-2013 |
20130287807 | COMPOUNDS FOR TREATING SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE - The present invention relates to a compound comprising a peptide for treating, preventing and/or ameliorating motor symptoms of Parkinson's disease, said peptide having a binding capacity to an antibody which is specific for an epitope of the amyloid-beta-peptide (Aβ). | 10-31-2013 |
20140179900 | TREATMENT OF ATHEROSCLEROSIS WITH CHOLESTEROL ESTER TRANSPORT PROTEIN MIMOTOPES - The present invention relates to the use of compounds for producing a medicament for preventing and/or treating atherosclerosis, atherosclerosis risk diseases and atherosclerosis sequelae. | 06-26-2014 |
20140234877 | METHOD FOR DETECTING A BETA-SPECIFIC ANTIBODIES IN A BIOLOGICAL SAMPLE - Disclosed is a method for detecting Aβ-specific antibodies in a biological sample comprising the following steps:—contacting the sample with Aβ-aggregates or with particles comprising Aβ-aggregate like surfaces and allowing the Aβ-specific antibodies to bind to the Aβ-aggregates, and -detecting the Aβ-specific antibodies bound to the Aβ-aggregates by a single particle detection technique, preferably by fluorescence activated cell sorting FACS. | 08-21-2014 |
20140242727 | METHOD FOR DIAGNOSING ALZHEIMER'S DISEASE (AD) - Disclosed is a method for diagnosing Alzheimer's disease (AD) wherein Aβ-specific antibodies in a biological sample of a person that is suspected of having AD are detected comprising the following steps: —contacting the sample with Aβ-aggregates or with particles having Aβ-aggregate like surfaces and allowing the Aβ-specific antibodies to bind to the Aβ-aggregates, and —detecting the Aβ-specific antibodies bound to the Aβ-aggregates by a single particle detection technique, preferably by fluorescence activated cell sorting (FACS); and wherein the amount of Aβ-specific antibodies detected is compared with the amount in a sample of known AD status. | 08-28-2014 |
20140255435 | Vaccine - Vaccine comprising a peptide bound to a pharmaceutically acceptable carrier, said peptide having the amino acid sequence | 09-11-2014 |
20150093431 | COMPOSITIONS - The present invention relates to a composition comprising at least one mimotope of an epitope of alpha-synuclein for use in a method for preventing and/or treating synucleinopathies, wherein said at least one mimotope is coupled or fused to a pharmaceutically acceptable carrier protein selected from the group consisting of a non-toxic diphtheria toxin mutant, keyhole limpet hemocyanin (KLH), diphtheria toxin (DT), tetanus toxid (TT) and | 04-02-2015 |
20150093432 | COMPOSITION - The present invention relates to a composition comprising at least one mimotope of an epitope of alpha-synuclein for use in a method for preventing and/or treating β-amyloidoses including Alzheimer's disease, wherein said at least one mimotope is coupled or fused to a pharmaceutically acceptable carrier protein selected from the group consisting of a non-toxic diphtheria toxin mutant, keyhole limpet hemocyanin (KLH), diphtheria toxin (DT), tetanus toxid (TT) and | 04-02-2015 |
20150125488 | METHODS AND COMPOSITIONS INVOLVING IMMUNOSTIMULATORY OLIGODEOXYNUCLEOTIDES - Described is an immunostimulatory oligodeoxynucleic acid molecule (ODN) having the structure according to formula (I), wherein any NMP is a 2′ deoxynucleoside monophosphate or monothiophosphate, selected from the group consisting of deoxyadenosine-, deoxyguanosine-, deoxyinosine-, deoxycytosine-, deoxyuridine-, deoxythymidine-, 2-methyl-deoxyinosine-, 5-methyl-deoxycytosine-, deoxypseudouridine-, deoxyribosepurine-, 2-amino-deoxyribosepurine-, -6-S-deoxyguanine-, 2-dimethyl-deoxyguanosine- or N-isopentenyl-deoxyadenosine-monophosphate or -monothiophosphate, NUC is a 2′ deoxynucleoside, selected from the group consisting of deoxyadenosine-, deoxyguanosine-, deoxyinosine-, deoxycytosine-, deoxyuridine-, deoxythymidine-, 2-methyl-deoxyinosine-, 5-methyl-deoxycytosine-, deoxypseudouridine-, deoxyribosepurine-, 2-amino-deoxyribosepurine-, 6-S-deoxyguanine-, 2-dimethyl-deoxyguanosine- or N-isopentenyl-deoxyadenosine, any X is O or S, a and b are integers from 0 to 100 with the proviso that a+b is between 4 and 150, B and E are common groups for 5′ or 3′ ends of nucleic acid molecules, as well as a pharmaceutical composition containing such ODNs. | 05-07-2015 |
20150306194 | METHOD FOR TREATING A SYNUCLEIOPATHY - A method for preventing and/or treating a synucleinopathy, comprising administering a composition containing at least one mimotope of an epitope of alpha-synuclein, wherein said at least one mimotope is coupled or fused to a pharmaceutically acceptable carrier protein selected from the group consisting of a non-toxic diphtheria toxin mutant, keyhole limpet hemocyanin (KLH), diphtheria toxin (DT), tetanus toxid (TT) and | 10-29-2015 |
Walter Schmidt, Wien AT
Patent application number | Description | Published |
---|---|---|
20090104211 | Treatment of atherosclerosis - The invention relates to a method and a device for commissioning articles from a first number of pick-up sections ( | 04-23-2009 |
20110166327 | APHERESIS DEVICE - The invention relates to an apharesis device for use in the treatment of Alzheimer patients. Said device comprises a solid support with which a flow of blood or plasma can be contacted. | 07-07-2011 |